Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease (Q63379392)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

title

Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

metabolic dysfunction–associated steatotic liver disease

26 April 2020

main subject

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

Nicolai Jacob Wewer Albrechtsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Jens Juul Holst

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Filip K Knop

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Matthias Mann

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

14

Timo D Müller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

author name string

Lili Niu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Philipp E Geyer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Lise L Gluud

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Alberto Santos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Sophia Doll

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Peter V Treit

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Tina Vilsbøll

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Anders Junker

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Stephan Sachs

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Kerstin Stemmer

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Matthias H Tschöp

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Susanna M Hofmann

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

language of work or name

English

0 references

publication date

1 March 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

Molecular Systems Biology

26 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

page(s)

e8793

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

The morphology of cirrhosis: definition, nomenclature, and classification

26 April 2020

cites work

1 reference

12 December 2020

Alpha-2-macroglobulin and hepatic fibrosis

1 reference

12 December 2020

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

12 December 2020

Mass spectrometry-based proteomics

1 reference

12 December 2020

Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.

1 reference

12 December 2020

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

1 reference

12 December 2020

Galectin-3 regulates myofibroblast activation and hepatic fibrosis

1 reference

12 December 2020

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

1 reference

12 December 2020

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

1 reference

12 December 2020

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

12 December 2020

Fatty liver: a novel component of the metabolic syndrome

1 reference

12 December 2020

Dipeptidyl peptidase IV (DDP IV) in NASH patients.

1 reference

12 December 2020

Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus

1 reference

12 December 2020

Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis

1 reference

12 December 2020

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

1 reference

12 December 2020

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

1 reference

12 December 2020

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

1 reference

12 December 2020

Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis.

1 reference

12 December 2020

Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.

1 reference

12 December 2020

Epidemiology of non-alcoholic fatty liver disease.

1 reference

12 December 2020

Significance of serum adiponectin levels in patients with chronic liver disease

1 reference

12 December 2020

Andromeda: a peptide search engine integrated into the MaxQuant environment

1 reference

12 December 2020

Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein

1 reference

12 December 2020

System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra HPLC runs on a bench top Orbitrap

1 reference

12 December 2020

Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe

1 reference

12 December 2020

Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism

1 reference

12 December 2020

Venous thromboembolism in cirrhosis

1 reference

12 December 2020

Next-generation proteomics: towards an integrative view of proteome dynamics.

1 reference

12 December 2020

Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.

1 reference

12 December 2020

Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women

1 reference

12 December 2020

Dipeptidyl peptidase-4: a key player in chronic liver disease

1 reference

12 December 2020

The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins

1 reference

12 December 2020

Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.

1 reference

12 December 2020

Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells

1 reference

12 December 2020

The human liver-specific proteome defined by transcriptomics and antibody-based profiling

1 reference

12 December 2020

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

1 reference

12 December 2020

Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus

1 reference

12 December 2020

Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ.

1 reference

12 December 2020

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

1 reference

12 December 2020

Functions of galectin-3 and its role in fibrotic diseases

1 reference

12 December 2020

Proteome sequencing goes deep.

1 reference

12 December 2020

Overview of the coagulation system

1 reference

12 December 2020

Biomarkers in nonalcoholic fatty liver disease

1 reference

12 December 2020

Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis

1 reference

12 December 2020

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.

1 reference

12 December 2020

Afamin--A pleiotropic glycoprotein involved in various disease states

1 reference

12 December 2020

2016 update of the PRIDE database and its related tools

1 reference

12 December 2020

Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.

1 reference

12 December 2020

Clinical applications, limitations and future role of transient elastography in the management of liver disease

1 reference

12 December 2020

Plasma Proteome Profiling to Assess Human Health and Disease

1 reference

12 December 2020

The Perseus computational platform for comprehensive analysis of (prote)omics data

1 reference

12 December 2020

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

1 reference

12 December 2020

Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance

1 reference

12 December 2020

Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

1 reference

12 December 2020

Mass-spectrometric exploration of proteome structure and function

1 reference

12 December 2020

Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis

1 reference

12 December 2020

Nonalcoholic steatohepatitis (NASH) drugs market

1 reference

12 December 2020

Proteomics reveals the effects of sustained weight loss on the human plasma proteome

1 reference

12 December 2020

Loss-less Nano-fractionator for High Sensitivity, High Coverage Proteomics

1 reference

12 December 2020

Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action

1 reference

12 December 2020

A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains

1 reference

12 December 2020

Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice

1 reference

12 December 2020

New trends on obesity and NAFLD in Asia

1 reference

12 December 2020

The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes.

1 reference

12 December 2020

Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals

1 reference

12 December 2020

Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis

1 reference

12 December 2020

Revisiting biomarker discovery by plasma proteomics.

1 reference

12 December 2020

Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease

1 reference

12 December 2020

Immunoglobulin A and liver diseases.

1 reference

12 December 2020

Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisis

1 reference

12 December 2020

High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case-c

1 reference

12 December 2020

A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials.

1 reference

12 December 2020

Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.

1 reference

12 December 2020

BoxCar acquisition method enables single-shot proteomics at a depth of 10,000 proteins in 100 minutes

1 reference

12 December 2020

Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial.

1 reference

12 December 2020

Mechanisms of NAFLD development and therapeutic strategies.

1 reference

12 December 2020

Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery

1 reference

12 December 2020

Identifiers

DOI

10.15252/MSB.20188793

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30824564%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

PubMed publication ID

30824564

1 reference